首页 > 专栏 > The Lancet Oncology The Lancet Oncology 共 35 条资讯 [News] Carcinogenicity of tris(chloropropyl) phosphate, butyraldehyde, and cumyl hydroperoxide [News] US oil blockade pushes Cuba's health system into crisis [News] US cancer vaccines research at “tipping point” as NCI backs $200 million initiative [News] Senators demand explanation for US Preventive Services Task Force halt [News] European Breast Cancer Conference 2026 [News] Canada's Yukon Territory publishes First Nations Cancer Strategy [Articles] Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial [News] UK MHRA–NICE pathway to create faster regulatory approval [News] Trump's 2027 budget calls for further cuts to health research [Articles] Estimating global cancer survival and mortality from 1990 to 2050: a simulation-based analysis of 17 cancers [Policy Review] International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment [Policy Review] Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC–ESTRO OligoCare consortium [Comment] AKT-targeted triplet therapy in advanced breast cancer [Perspectives] CHEMO MAN—or how we used to remember [Articles] Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort study [Articles] Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers [Perspectives] Turning breast cancer into art with Cancer Research UK [Articles] Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types [Articles] On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials [Articles] CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials 12下一页 » 相关分类 The Lancet Oncology ScienceDirect Publication: The Lancet Oncology The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi